Method for treating glaucoma
CA 2275827 C · Owner: Lefker, Bruce Allen · Inventors: Cameron, Kimberly O'Keefe; Lefker, Bruce Allen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is use of prostaglandin agonists for the reduction of intraocular pressure, and accordingly glaucoma. The prostaglandin agonists include those of the formula I: (wherein B is N; A is alkylsulfonyl or the like; Q is alkylene or the like; Z is carboxyl or the like; K is a bond alkylene, or the like and M is a ring).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 21, 1999 and granted August 5, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 21, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 21, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.